Skip to main content
April 1, 2014
Hitachi High-Technologies Corporation (TOKYO: 8036, Hitachi High-Tech) was included in "Global Niche Top Companies Selection 100 (GNT 100)," following approval and recognition by the Ministry of Economy, Trade and Industry (METI).
Under the "GNT 100" program, METI approves and recognizes companies that strive to capture global markets, secure high market share in niche sectors, and carry out healthy management as "GNT companies."
Hitachi High-Tech's capillary electrophoresis (CE) DNA sequencer was commended highly for its strategic nature, market share, international appeal and other attributes, leading to the Company's selection as a GNT company.
The CE DNA sequencer was developed by Hitachi High-Tech to analyze gene sequences. Sales of the CE DNA sequencer were initiated in 2000 by Hitachi High-Tech business partner Thermo Fisher Scientific Inc. (Headquarters: U.S.A.)'s Life Technologies, in combination with diagnostic reagents provided under the Life Technologies brand.
The CE DNA sequencer has been used in a broad range of research related to the life sciences, particularly biology and medicine. Notably, it played a prominent role in the Human Genome Project to determine the sequence of all the chemical base pairs which make up human DNA, which was completed in 2003. And in recent years, the CE DNA sequencer has become a core Hitachi High-Tech product that is also used in applied fields such as DNA profiling for forensic investigations and other purposes, and in genetic diagnosis.
Hitachi High-Tech's highly reliable CE DNA sequencer and its collaboration with Life Technologies, which is expanding sales and services for the device worldwide, have earned a strong reputation. The CE DNA sequencer has become the industry standard for genetic sequencing, and has captured an extremely high market share of the global market.
Emboldened by its inclusion in "GNT 100," Hitachi High-Tech will focus on driving further technological innovation and making deeper inroads into international markets.
Capillary electrophoresis (CE) DNA sequencer
Copyright © 2014 Life Technologies Corporation. Used under permission
Reiko Takeuchi, Aiko Matsumoto
CSR & Corporate Communications Dept.,
Hitachi High-Technologies Corporation